Sinocare Inc. (SHE:300298)
18.75
+0.30 (1.63%)
At close: Jan 23, 2026
Sinocare Revenue
Sinocare had revenue of 1.19B CNY in the quarter ending September 30, 2025, with 13.40% growth. This brings the company's revenue in the last twelve months to 4.71B, up 12.10% year-over-year. In the year 2024, Sinocare had annual revenue of 4.44B with 9.47% growth.
Revenue (ttm)
4.71B
Revenue Growth
+12.10%
P/S Ratio
2.20
Revenue / Employee
980.32K
Employees
5,014
Market Cap
10.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.44B | 384.34M | 9.47% |
| Dec 31, 2023 | 4.06B | 106.37M | 2.69% |
| Jan 1, 2023 | 3.95B | 1.59B | 67.38% |
| Jan 1, 2022 | 2.36B | 346.09M | 17.17% |
| Dec 31, 2020 | 2.02B | 237.00M | 13.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 9.58B |
| Cofoe Medical Technology | 3.13B |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.57B |
| Qingdao Haier Biomedical Co.,Ltd | 2.26B |
| Edan Instruments | 1.90B |
| INKON Life Technology | 1.69B |
| Beijing Wandong Medical Technology | 1.62B |
| Shanghai MicroPort Endovascular MedTech | 1.25B |